Your session is about to expire
← Back to Search
Cognitive Task Analysis for Epilepsy and Brain Cancer
N/A
Recruiting
Led By Nitin Tandon, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, during stimulation( about 2 seconds after baseline )
Awards & highlights
No Placebo-Only Group
Summary
This trial compares how normal brain function is organized using fMRI in normal people and those with epilepsy or brain tumors, to understand the role of specific brain regions in cognitive processes.
Who is the study for?
This trial is for English-speaking patients with medically refractory epilepsy or brain tumors near crucial brain regions. They may have electrodes implanted to locate seizure sites and map critical areas, or they might undergo intra-op mapping, a Wada test, or an awake craniotomy.
What is being tested?
The study aims to compare normal brain function using fMRI in healthy subjects versus those with epilepsy or brain tumors. It involves language-based tasks and will use data from intracranial recordings to analyze information flow between brain areas.
What are the potential side effects?
There are no direct side effects mentioned for participating in this trial since it involves non-invasive imaging and cognitive tests. However, there could be general risks associated with fMRI scanning such as discomfort from lying still.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, during stimulation( about 2 seconds after baseline )
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, during stimulation( about 2 seconds after baseline )
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in reaction times in milliseconds
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Neural recordings and stimulation during language tasksExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
347,785 Total Patients Enrolled
8 Trials studying Epilepsy
434 Patients Enrolled for Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,384 Previous Clinical Trials
652,613 Total Patients Enrolled
79 Trials studying Epilepsy
25,486 Patients Enrolled for Epilepsy
Nitin Tandon, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
8 Total Patients Enrolled
1 Trials studying Epilepsy
8 Patients Enrolled for Epilepsy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have significant brain abnormalities that could affect critical areas.I cannot participate in tests due to cognitive or intellectual disabilities.I have a brain condition and may need or had surgery involving brain function tests.I have epilepsy that doesn't respond to medication and will have or had surgery to place electrodes in my brain.
Research Study Groups:
This trial has the following groups:- Group 1: Neural recordings and stimulation during language tasks
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.